Rhode Island Hospital won an $11 million grant from the National Institutes of Health to develop stem-cell-based treatments for lung and marrow diseases.
Rhode Island Hospital landed a five-year, $11.1 million grant from the National Institutes of Health to develop stem-cell-based treatments for lung and bone marrow diseases.
The grant, part of the NIH's Centers of Biomedical Research Excellence program, will help fund RHI's research on stem cell biology, aimed at identifying new approaches to tissue reconstruction in lung and marrow diseases. One of its main objectives is to move from basic stem cell studies to clinical trials.
The NIH also doled out $9.3 million to Clemson University for its research on tissue restoration to relieve end-stage organ failure and tissue loss.
The COBRE program aims to boost multidisciplinary centers that concentrate on one core area of research, part of the NIH's Institutional Development Award program for states that historically haven't received much NIH funding.
Warren Watson, a 30-year Medtronic Inc. employee with family connections to founder Earl Bakken, is...
Quidel Corp. wins Food & Drug Administration 510(k) clearance for its chorionic gonadotropin-...
Ann Arbor, Mich.-based HistoSonics Inc. snags former Food & Drug Administration commissioner Dr....
The Food & Drug Administration releases a list of the medical devices it granted 510(k) clearance...
A federal grand jury indicts former Spectranetics CEO John Schulte, two other executives and a...